Quick Answer
CV Sciences, Inc. reported Operating Income Loss of -$470.0 thousand for the year ending 2025.
- CV Sciences, Inc. showed an increase of +78.5% in Operating Income Loss from 2024 to 2025.
- This data is from CV Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: -$327.6 thousand | Q3 2013: -$676.3 thousand | Q1 2014: $535.5 thousand | Q2 2014: $131.9 thousand | Q3 2014: -$490.3 thousand | Q1 2015: -$2.69 million | Q2 2015: -$2.00 million | Q3 2015: -$902.2 thousand | Q1 2016: -$1.21 million | Q2 2016: -$2.06 million | Q3 2016: -$1.58 million | Q1 2017: -$3.65 million | Q2 2017: -$859.7 thousand | Q3 2017: -$481.8 thousand | Q1 2018: $668.0 thousand | Q2 2018: $3.30 million | Q3 2018: $3.53 million | Q1 2019: -$9.38 million | Q2 2019: $1.25 million | Q3 2019: -$1.77 million | Q1 2020: -$5.32 million | Q2 2020: -$4.66 million | Q3 2020: -$3.15 million | Q1 2021: -$3.11 million | Q2 2021: -$3.51 million | Q3 2021: -$2.98 million | Q1 2022: -$1.52 million | Q2 2022: -$2.32 million | Q3 2022: -$892.0 thousand | Q1 2023: $5.76 million | Q2 2023: -$1.08 million | Q3 2023: -$437.0 thousand | Q1 2024: -$620.0 thousand | Q2 2024: -$583.0 thousand | Q3 2024: -$341.0 thousand | Q1 2025: $11.0 thousand | Q2 2025: -$131.0 thousand | Q3 2025: -$275.0 thousand.
- Over the full 14 years of available data (2012 to 2025), CV Sciences, Inc.'s Operating Income Loss has declined by 992.6%.
- Historical annual values: Fiscal year 2025: -$470.0 thousand | Fiscal year 2024: -$2.19 million | Fiscal year 2023: $3.36 million | Fiscal year 2022: -$6.85 million | Fiscal year 2021: -$18.45 million | Fiscal year 2020: -$22.59 million | Fiscal year 2019: -$17.24 million | Fiscal year 2018: $10.25 million | Fiscal year 2017: -$4.86 million | Fiscal year 2016: -$13.07 million | Fiscal year 2015: -$11.21 million | Fiscal year 2014: -$8.55 million | Fiscal year 2013: -$1.62 million | Fiscal year 2012: -$43.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: